Involvement of p53 in the cytotoxic activity of the NAMPT inhibitor FK866 in myeloid leukemic cells
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
FK866 is a specific inhibitor of NAMPT and induces apoptosis of leukemic cells by depletion of intracellular NAD+. Since up‐regulation of NAMPT is associated with several cases of cancers, including leukemias, we asked whether in leukemic cells inhibition of NAMPT involves p53 pathway. We observed that FK866 induced apoptosis and reduced cell proliferation in NB‐4, OCI‐AML3 and MOLM‐13 cell lines. In contrast, the leukemia cell lines, K‐562 and Kasumi, containing nonfunctional p53 were relatively unaffected by FK866 treatment. Importantly, direct inhibition of sirtuins significantly reduced the viability of NB‐4, OCI‐AML3 and MOLM‐13 cell lines. Activation of p53 by FK866 involved increased acetylation of p53 at lysine 382 with subsequent increase in the expression of p21 and BAX. Further, knockdown of p53 attenuated the effects of FK866 on apoptosis and cell cycle arrest, which was partly associated with decreased expression of p21 and BAX. Our results suggest the role of p53 acetylation pathway in the anti‐leukemic effect of FK866.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Transcriptional control of human p53-regulated genes
Riley, T., Sontag, E., Chen, P., & Levine, A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2395 · Cited by 1,921 · cited 1×
“In the presence of genotoxic stress, activation of p53 involves regulation of key cellular processes such as DNA repair, cell-cycle arrest, senescence and apoptosis.(23) Because FK866 affected both, cell proliferation and viability, we performed AnnexinV/7-AAD staining and BrdU incorporation assay to measure apoptosis…”
MethodRestoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound
Bykov, V. J. N., Issaeva, N., Shilov, A., Hultcrantz, M., Pugacheva, E., Chumakov, P., Bergman, J., Wiman, K. G., & Selivanova, G. (2002) · Nature Medicine · doi:10.1038/nm0302-282 · Cited by 1,067 · cited 1×
“In addition, restoring wild type functions to mutant p53 by using small molecule inhibitors has proven to be an effective strategy to induce apoptosis in cancer cells.(37,38) Our results obtained in the NB-4 cell line indicate that FK866-mediated acetylation of mutant p53 restores its ability to execute tumor suppress…”
BackgroundRevollo, J. R., Grimm, A. A., & Imai, S.-I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408388200 · Cited by 1,010
Bitterman, K. J., Anderson, R. M., Cohen, H. Y., Latorre-Esteves, M., & Sinclair, D. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205670200 · Cited by 1,002 · cited 1×
“Intriguingly, the specificity of NA on SIRT1 is quite unclear due to its dual ability to either activate or inhibit SIRT1, depending on the dose and context.(45,47) Despite its use in the clinical trials as a therapy for cancers,(48) further detailed investigation of its effects at molecular level is required.”
BackgroundAcetylation Is Indispensable for p53 Activation
Tang, Y., Zhao, W., Chen, Y., Zhao, Y., & Gu, W. (2008) · Cell · doi:10.1016/j.cell.2008.03.025 · Cited by 838
The NAD biosynthesis inhibitor APO866 has potent antitumor activity against hematologic malignancies
Nahimana, A., Attinger, A., Aubry, D., Greaney, P., Ireson, C., Thougaard, A. V., Tjørnelund, J., Dawson, K. M., Dupuis, M., & Duchosal, M. A. (2009) · Blood · doi:10.1182/blood-2008-08-173369 · Cited by 190 · cited 2×
“In contrast, the normal hematopoietic progenitor cells remain unaffected.(18,20) This might be explained by the fact that the metabolic rate of cancer cells is abnormally high, and therefore, they require higher NADþ levels.”
Background
Cited by
Physiological and pathophysiological roles of NAMPT and NAD metabolism.
Garten, A., Schuster, S., Penke, M., Gorski, T., de Giorgis, T., & Kiess, W. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.117 · Cited by 708
The emerging link between cancer, metabolism, and circadian rhythms
Masri, S., & Sassone-Corsi, P. (2018) · Nature Medicine · doi:10.1038/s41591-018-0271-8 · Cited by 404
Inhibition of NAMPT decreases cell growth and enhances susceptibility to oxidative stress
Xu, R., Yuan, Z., Yang, L., Li, L., Li, D., & Lv, C. (2017) · Oncology Reports · doi:10.3892/or.2017.5793 · Cited by 36
Cea, M., Cagnetta, A., Acharya, C., Acharya, P., Tai, Y.-T., Yang, C., Lovera, D., Soncini, D., Miglino, M., Fraternali-Orcioni, G., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0630 · Cited by 28
“(7, 8) Based on these 50 observations, tumor cells are more susceptible to Nampt inhibition than normal cells.(8-12) 51 Indeed, targeting Nampt with the specific inhibitor FK866 represents a novel therapeutic strategy 52 for human cancer.”
Background
Metadata
- Authors
- Thakur, B. K., Dittrich, T., Chandra, P., Becker, A., Kuehnau, W., Klusmann, J., Reinhardt, D., & Welte, K.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2012-08-12
- Volume
- 132
- Issue
- 4
- Pages
- 766-774
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W1992969032
- Cited by
- 53
- References
- 6
- FWCI
- 2.38
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Involvement of p53 in the cytotoxic activity of the NAMPT inhibitor FK866 in myeloid leukemic cells. https://app.cochat.ai/papers/10.1002/ijc.27726
- The paper
- Thakur, B. K., Dittrich, T., Chandra, P., Becker, A., Kuehnau, W., Klusmann, J., Reinhardt, D., & Welte, K. (2013). Involvement of p53 in the cytotoxic activity of the NAMPT inhibitor FK866 in myeloid leukemic cells. International Journal of Cancer. https://doi.org/10.1002/ijc.27726
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.